Navigation Links
Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology
Date:6/30/2008

PITTSBURGH, June 30 /PRNewswire/ -- Cellumen, Inc., the Cellular Systems Biology Company, announced today the initiation of a research collaboration with the National Center for Toxicology Research (NCTR), a research center of the Food and Drug Administration (FDA). Under the agreement, Cellumen will use its proprietary CellCiphr(R) toxicity risk assessment technology to profile blinded samples of known liver toxicity compounds including both failed and marketed drugs for the NCTR. The NCTR will incorporate the knowledge generated by Cellumen to develop a liver toxicity knowledge base. Cellumen will use the profiling data and compound safety data from the collaboration to further develop the diversity in the CellCiphr database and the types of cell panels, as well as to advance the classifier informatics tools.

"Failure to predict human toxicity among drug candidates early in the discovery/development process is a leading challenge for the pharmaceutical industry," stated D. Lansing Taylor, Ph.D., CEO of Cellumen. "Patients demand and deserve safe and effective drugs, while pharmaceutical companies are increasingly challenged to profitably meet that demand. Cellumen's vision is working toward the goal of replacing animal testing with a human in vitro system in order to facilitate the development of safer, more effective drugs," added Dr. Taylor.

By applying CellCiphr toxicity profiling early in the discovery and lead optimization phases, drug companies will accurately identify compounds with high human toxic liabilities. Actions can be taken to either de-prioritize high-risk compounds, or remove high-risk compounds from a lead series that ultimately would prove to be toxic. Cellumen is at the forefront of drug safety profiling services to aid in predicting drug toxicity early in the discovery/development process.

About Cellumen:

Cellumen is the leading innovator in cellular systems biology (CSB(TM)) solutions providing the most acc
'/>"/>

SOURCE Cellumen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cellumen Establishes Collaboration in Breast Cancer Patient Stratification
2. ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. LI-COR(R) Biosciences and Tiger Woods Learning Center Collaborate to Develop High School Curriculum in Genetics
5. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
6. Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization
7. Fred Hutchinson Cancer Research Center and NSB POSTECH, Inc. to Collaborate on Development of New Class of Proteomic Microarrays
8. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
9. Singulex Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program
10. NIH collaborates with EPA to improve the safety testing of chemicals
11. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...tario, Nov. 24 Dow AgroS... assets of Hyland Seeds, a division of Thompsons L...d Seeds will further expand Dow AgroSciences, curr...introduction of SmartStax(TM) in 2010 and Do... in corn in 2012. The transactional close is expec...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Sigma-Aldrich Corporation ...OMX conference on Tuesday, December 1st at 1:45 PM... may listen via live audio broadcast over the Inte... a ldrich.com/ . Users can click the "Webcast" ...drich: Sigma-Aldrich is a leading Life Science a...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
(Date:11/24/2009)...ov. 24 NeurogesX, Inc. (...ed on developing and commercializing novel pain ma...iTonno, President and Chief Executive Officer, is ...ray Health Care Conference, to be held December 1-...New York. ,, Mr. DiTonno and Stephen Ghiglieri...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...s. The Wisconsin Alumni Research Foundation ha...ed with the organization since December 1 and was ...he patents generated by University of Wisconsin-Ma...where, and invests part of its $1.4 billion portfo...er replaced Mark Bear, who retired at the beginnin...
...you see that cloud, thats almost in shape like a c..., indeed. ,Hamlet: Methinks it is like a weasel. ,... like a whale? ,Polonius: Very like a whale. , Ha...William Shakespeare) , ,Occasionally stumbling ac...ius was a hack consultant to Denmarks king. Hamlet...
...Wis. At least 170 potentially fraudulent Web sit...the Indian Ocean tsunami have turned up in a searc...d protection company, and MasterCard Internation... order to pinpoint and suspend the activity of Web...lent online activities such as identity theft. The...
Other Biology Technology:New WARF investment director plans to keep steady course 2Follow these three rules when choosing tech consultants 2Follow these three rules when choosing tech consultants 3Follow these three rules when choosing tech consultants 4NameProtect roots out fake tsunami-related donation sites 2
(Date:11/24/2009)... Antarctica has long held secrets of the earth,s ...ly, there has been very little information on the ...f ice for millions of years. Now, a team of resear...been funded to the tune of $10 million dollars by ... the bottom of things literally. These scientists...
(Date:11/23/2009)... research presents strong evidence that the "syner...oor traffic-related pollution and indoor endotoxin...the other exposure alone. , Environmental heal... College of Medicine have shown that children expo...es and indoor endotoxin during early life are six ...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 1Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 1Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 3Next Generation Hemostatic Dressing Available for Military Emergencies 52198 1Next Generation Hemostatic Dressing Available for Military Emergencies 52198 2Next Generation Hemostatic Dressing Available for Military Emergencies 52198 3
...Institute have discovered a new mechanism responsi...y which organs locate themselves on the left or ri...l mechanism, garnered through the study of three d...h), marks the first time that a single common mech... in three distinct species. Such a discovery may ...
...that all cloned animals are biologically flawed. B... cells derived from cloned embryos, the basis for ... nuclear transfer, therapeutic cloning is a promis...lular therapies for treating certain disorders. De...th stem cells derived from a cloned embryo. But if...
...t make up our bodies, nothing is more ubiquitous t...al protein in the body, reinforcing connective tis...bles to strengthen tendons. Collagen forms sheets ... organ. There is nothing in the body, in fact, tha...edicine, collagen from animals, principally cows, ...
Other Biology News:Forsyth scientists gain greater understanding of how embryos differentiate left from right 2Forsyth scientists gain greater understanding of how embryos differentiate left from right 3Cloned stem cells prove identical to fertilized stem cells 2Cloned stem cells prove identical to fertilized stem cells 3Wisconsin scientists find a way to make human collagen in the lab 2Wisconsin scientists find a way to make human collagen in the lab 3
... System provides optimized reagents and protocols ... genes by insertion of group II introns. The metho...rons and utilizes a simple PCR step to re-target t...n into the host genome. Utility of the technology ...
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Biology Products: